Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
May 10, 2005	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-05-000029.pdf 0001237899-05-000029.xls
May 09, 2005	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0000950123-05-005904.pdf 0000950123-05-005904.xls
Apr 29, 2005	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	View HTML 0001206774-05-000747.pdf 0001206774-05-000747.xls
Apr 28, 2005	8-K	Report of unscheduled material events or corporate event	View HTML 0000950172-05-001375.pdf
Apr 14, 2005	8-K	Report of unscheduled material events or corporate event	View HTML 0000950172-05-001189.pdf 0000950172-05-001189.xls
Apr 01, 2005	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0000950123-05-004013.pdf
Apr 01, 2005	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000950123-05-004016.pdf
Mar 11, 2005	10-K	Annual report which provides a comprehensive overview of the company for the past year	View HTML 0000950123-05-002979.pdf 0000950123-05-002979.xls
Mar 01, 2005	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-05-000026.pdf 0001237899-05-000026.xls
Feb 23, 2005	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-05-000025.pdf 0001237899-05-000025.xls

Data provided by Kaleidoscope.

Investors & Media